• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 11 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Chirag Walia, India

      Chirag Walia, India
      ChiragWalia

    • Murat Morali, Turkey

      Murat Morali, Turkey

    • Fabrice Kamp, Germany

      Fabrice Kamp, Germany

    • Karl Hughes, Ireland

      Karl Hughes, Ireland

    • Enzo Maccarrone, Italy

      Enzo Maccarrone, Italy

    • Emilienne Verhaegen, Belgium

      Emilienne Verhaegen, Belgium

    • Willi Klein, UK

      Willi Klein, UK

    • Mona H. Bahus and Camilla Knoff Glomstad, Norway

      Mona H. Bahus and Camilla Knoff Glomstad, Norway

    • Marcel R. Wernard, Netherlands

      Marcel R. Wernard, Netherlands

    • Magdalena Ayala Rodríguez, Mexico

      Magdalena Ayala Rodríguez, Mexico

    • Carlos Alberto Arango, Colombia

      Carlos Alberto Arango, Colombia

    • Anita Forte, USA

      Anita Forte, USA

    • Andrew Langat, Kenya

      Andrew Langat, Kenya

    • Den Haag, Netherlands

      Den Haag, Netherlands

    • Cath Muir, UK

      Cath Muir, UK
      Cath

    • Mike Rannie, Canada

      Mike Rannie, Canada

    • PALS and CALS, Singapore

      PALS and CALS, Singapore

    • Lucy Lintott, Scotland

      Lucy Lintott, Scotland

    • Marco Antonio Alvarez Mercado, Mexico

      Marco Antonio Alvarez Mercado, Mexico

    • Chih Ching Darren Wong, Malaysia

      Chih Ching Darren Wong, Malaysia

    • Bob Spurrier, USA

      Bob Spurrier, USA

    • Camilla Heiberg Freiberg, Denmark

      Camilla Heiberg Freiberg, Denmark

    • Mike Cels, Canada

      Mike Cels, Canada

    • Bjarne Hytjanstorp, Norway

      Bjarne Hytjanstorp, Norway

    • Inta Grubb, Australia

      Inta Grubb, Australia

    • Jo Knowlton, Scotland

      Jo Knowlton, Scotland

    • Federica Mastrosimone, Italy

      Federica Mastrosimone, Italy

    • H. Todd Kelly, USA

      H. Todd Kelly, USA

    • Olga Cosentino, Argentina

      Olga Cosentino, Argentina

    • Nicholas (Nic) Bowman, South Africa

      Nicholas (Nic) Bowman, South Africa

    • Zelina Brito, Brazil

      Zelina Brito, Brazil

    • Jorge Melo, Brazil

      Jorge Melo, Brazil

    • Monica Soriano, Argentina

      Monica Soriano, Argentina

    • Norm MacIsaac, Canada

      Norm MacIsaac, Canada

    • Luis Antonio Pimenta Lima, Brazil

      Luis Antonio Pimenta Lima, Brazil

    • Claudette Sturk, Canada

      Claudette Sturk, Canada
      Picture2

    • Sam Hayden-Harler, UK

      Sam Hayden-Harler, UK

    • Jean Waters, UK

      Jean Waters, UK

    • Lombana, Spain

      Lombana, Spain

    • Robbie Caliste, UK

      Robbie Caliste, UK

    • Jon Newsome, USA

      Jon Newsome, USA

    • Josée Kolijn-de Man, Netherlands

      Josée Kolijn-de Man, Netherlands

    • Mike Small, UK

      Mike Small, UK

    • Sharon Corosanite, USA

      Sharon Corosanite, USA

    • Wiebke Braach, Germany

      Wiebke Braach, Germany

    • Eddy LeFrançois, Canada

      Eddy LeFrançois, Canada

    • Ali Var, Turkey

      Ali Var, Turkey

    • Lineke Veenstra, Netherlands

      Lineke Veenstra, Netherlands

    • Dr. Shelly Hoover, USA

      Dr. Shelly Hoover, USA

    • Horacio Fritzer, Argentina

      Horacio Fritzer, Argentina

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login